# AETHLON MEDICAL INC (AEMD) — capital_raise/public_offering [completed]
Source: SEC API (secapi.ai) · situation sit_e5a54a05209209f9da9b · retrieved 2026-08-11T16:15:06.685Z

## Overview
Aethlon Medical, Inc. is a Nevada corporation engaged in the development of medical devices and technologies; the company is classified under surgical and medical instruments and apparatus.

On July 6, 2026, Aethlon Medical, Inc. entered into a Securities Purchase Agreement with investors to conduct a registered public offering. The Company sold 263,000 shares of common stock and pre-funded warrants together with 5,633,009 common warrants and 225,320 placement agent warrants at a combined public offering price of $0.71 per share and accompanying warrant. The offering closed on July 7, 2026, generating gross proceeds of approximately $4,000,000. After deducting Maxim Group LLC's placement agent fees (6.25% of gross proceeds, or $260,000) and estimated offering expenses, net proceeds to the Company were approximately $3,335,000. The common warrants have an exercise price of $0.71 per share and are exercisable upon stockholder approval or if pricing conditions are met. The pre-funded warrants have a nominal exercise price of $0.001 per share. The placement agent warrants have a five-year term, are exercisable commencing six months from closing, and have an exercise price of $0.71 per share.

## Terms
- Counterparty: Maxim Group LLC (placement agent); certain investors · Consideration: mixed · Price/share: $0.71

## Key dates
- Completed 2026-07-07

## Timeline
- 2026-07-07 · 8-K (0001683168-26-005338): Aethlon Medical raises $4M in registered offering; issues 263K shares, 11.2M warrants at $0.71 — *Aethlon Medical, Inc. is a Nevada corporation engaged in the development of medical devices and technologies; the company is classified under surgical and medical instruments and apparatus.* On July 6, 2026, Aethlon Medical, Inc. entered into a Securities Purchase Agreement with investors to conduct a registered public offering. The Company sold 263,000 shares of common stock and pre-funded warrants together with 5,633,009 common warrants and 225,320 placement agent warrants at a combined public offering price of $0.71 per share and accompanying warrant. The offering closed on July 7, 2026, generating gross proceeds of approximately $4,000,000. After deducting Maxim Group LLC's placement agent fees (6.25% of gross proceeds, or $260,000) and estimated offering expenses, net proceeds to the Company were approximately $3,335,000. The common warrants have an exercise price of $0.71 per share and are exercisable upon stockholder approval or if pricing conditions are met. The pre-funded warrants have a nominal exercise price of $0.001 per share. The placement agent warrants have a five-year term, are exercisable commencing six months from closing, and have an exercise price of $0.71 per share.
  https://www.sec.gov/Archives/edgar/data/882291/0001683168-26-005338.txt

## Citations
- 0001683168-26-005338 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000168316826005338